DIFFUSION OF CEFPIROME INTO THE CEREBROSPINAL-FLUID OF PATIENTS WITH PURULENT-MENINGITIS

被引:19
作者
WOLFF, M
CHAVANET, P
KAZMIERCZAK, A
PECHINOT, A
DEMATONS, C
PORTIER, H
LENFANT, B
机构
[1] HOP BOCAGE,SERV MALAD INFECT,F-21034 DIJON,FRANCE
[2] HOP BOCAGE,SERV MICROBIOL MED,F-21034 DIJON,FRANCE
[3] INST ROUSSEL UCLAF,ROMAINVILLE,FRANCE
关键词
D O I
10.1093/jac/29.suppl_A.59
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We evaluated the diffusion of cefpirome into the cerebrospinal fluid (CSF) of 25 patients with bacterial meningitis or ventriculitis who were receiving conventional antibiotic treatment A single cefpirome dose of 2 g was infused at day 2-3 after the onset of therapy. Concentrations of cefpirome in serum and CSF obtained at 2, 4, 8 or 12 h after the infusion were determined by high-performance liquid chromatography. The mean (±s.e.m.) concentrations of cefpirome in CSF ranged from 2-26± 116 to 417 ±083 mg/L. These concentrations were higher than the MBCs for the pathogens usually responsible for bacterial meningitis. © 1992 Oxford University Press.
引用
收藏
页码:59 / 62
页数:4
相关论文
共 4 条
[1]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ASSAY AND PHARMACOKINETICS OF HR-810 AFTER INTRAMUSCULAR INJECTION IN RABBITS [J].
BAWDON, RE ;
LU, YS ;
BRATER, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (04) :436-438
[2]   CORRELATION OF INVITRO TIME-KILL CURVES AND KINETICS OF BACTERIAL KILLING IN CEREBROSPINAL-FLUID DURING CEFTRIAXONE THERAPY OF EXPERIMENTAL ESCHERICHIA-COLI MENINGITIS [J].
DECAZES, JM ;
ERNST, JD ;
SANDE, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) :463-467
[3]   THE INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF CEFPIROME (HR-810), A PYRIDINE CEPHALOSPORIN AGENT ACTIVE AGAINST STAPHYLOCOCCI, ENTEROBACTERIACEAE AND PSEUDOMONAS-AERUGINOSA [J].
NEU, HC ;
CHIN, NX ;
LABTHAVIKUL, P .
INFECTION, 1985, 13 (03) :146-155
[4]   NEW CEPHALOSPORINS CEFOTAXIME, CEFPIMIZOLE, BMY 28142, AND HR 810 IN EXPERIMENTAL PNEUMOCOCCAL MENINGITIS IN RABBITS [J].
TAUBER, MG ;
HACKBARTH, CJ ;
SCOTT, KG ;
RUSNAK, MG ;
SANDE, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :340-342